IDEXX Laboratories Aktie
| 561,78USD | 16,05USD | 2,94% |
WKN: 888210 / ISIN: US45168D1046
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 10 350 | 10 780 | 11 000 | 11 000 | 11 000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,31 | 0,31 | 0,33 | 0,35 | 0,39 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 900 | 1 044 | 1 441 | 1 338 | 1 340 |
| Summe Anlagevermögen | 1 537 | 1 703 | 1 819 | 1 955 | 2 010 |
| Summe Aktiva | 2 437 | 2 747 | 3 260 | 3 293 | 3 351 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 747 | 2 138 | 1 775 | 1 698 | 1 745 |
| Summe Eigenkapital | 690 | 609 | 1 485 | 1 595 | 1 605 |
| Summe Passiva | 2 437 | 2 747 | 3 260 | 3 293 | 3 351 |
Adresse
| One IDEXX Drive, 04092-2040 Westbrook | |
| Telefon | +1 (207) 556-0300 |
| Internet | http://www.idexx.com |
Management
|
Amit Gupta
Senior VP, Chief Digital & Information Officer |
|
Andrew J. Emerson
Chief Financial Officer, Treasurer & Executive VP |
|
Bruce L. Claflin
Independent Director |
|
Daniel M. Junius
Independent Director |
|
George J. Fennell
EVP-Global Companion Animal Group Commercial |
|
Irene Chang Britt
Independent Director |
|
Jason W. Johnson
Chief Medical Officer & Senior Vice President |
|
Jeffery Donn Chadbourne
SVP-Commercial Finance & Sales Operations |
|
John Ravis
Head-Investor Relations |
|
Jonathan J. Mazelsky
Executive Chairman |
|
Joseph L. Hooley
Independent Director |
|
Julie Godon
Senior Vice President & Global Marketing Officer |
|
Karen Peacock
Independent Director |
|
Lawrence D. Kingsley
Lead Independent Director |
|
Martin Alexander Smith
CTO, EVP-Global Operations, Research & Development |
|
Michael Erickson
President, Chief Executive Officer & Director |
|
Michael J. Lane
EVP & GM-Companion Animal Group Diagnostics |
|
Michael P. Johnson
Chief Human Resources Officer & Executive VP |
|
Michael Schreck
EVP, GM-Corporate Accounts & Customer Experience |
|
Murthy Yerramilli
SVP-Assay, Instrument Research & Development |
|
Sam A. Samad
Independent Director |
|
Sharon E. Underberg
Secretary, Executive VP & General Counsel |
|
Sophie V. Vandebroek
Independent Director |
|
Stuart M. Essig
Independent Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.